- Home
- LUCY vs IMCC Comparison
LUCY vs IMCC Comparison
Compare LUCY & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUCY | IMCC |
|---|---|---|
| Founded | 2017 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 10.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | LUCY | IMCC |
|---|---|---|
| Price | $1.42 | $1.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 279.8K | 208.3K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,392,547.00 | ★ $37,606,703.00 |
| Revenue This Year | $80.76 | $47.12 |
| Revenue Next Year | $210.34 | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.22 | 1.92 |
| 52 Week Low | $1.29 | $0.93 |
| 52 Week High | $7.08 | $7.12 |
Technical Indicators
Market Signals| Indicator | LUCY | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 46.39 |
| Support Level | $1.38 | $1.54 |
| Resistance Level | $1.68 | $2.08 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 27.91 | 18.58 |
Price Performance
Historical ComparisonAbout LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.